Leading provider for specialty Copolyester solutions Selenis has announced the launch of Selcare CE 500, a low glycol modified polymer resin engineered specifically for film extrusion in healthcare packaging, through its dedicated healthcare brand, Selcare.
This ‘breakthrough’ product is engineered as recycle-ready material that meets the requirements for RIC1 identification. Selcare CE 500 is introduced as part of the Selcare medical grade range, which has a strong focus on sustainability according to the company.
Eduardo Santos, Global Head of Strategy for Selcare said: “Our innovative batch production technology has enabled Selcare to develop a low glycol modified polyester that delivers exceptional performance, designed to be recycled in the RIC 1 stream.
“This tailor-made glycol modification provides improved processability, superior sealing, and enhanced impact resistance compared to existing modified APETs. By offering this at a price point between standard APET and PETG healthcare grades, Selcare CE 500 is a truly cost-competitive and sustainable solution that facilitates closing loops in healthcare packaging.”
The new resin comes with regulatory declarations, including ISO 10993, USP Class VI, USP <661.1>, and ICH Q3D. The product is also free of intentionally added BPA says the company.
Related
The post Selenis launches Selcare CE 500 for medical device packaging first appeared on TechToday.
This post originally appeared on TechToday.